Both cumulative use and recent cannabis use are associated with poorer objective sleep quality, as suggested in a study.
Researchers analysed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up, and the CARDIA Year-35 Sleep Ancillary Study. The analysis included 1,266 participants, including 891 (mean age at year-35 examination 60.7 years, 63.3 percent female, 41 percent Black) with objective sleep data and 1,128 with subjective sleep data.
Cannabis use was categorized as cumulative (calculated in cannabis-years, with 1 cannabis-year equating to 365 days of use) and recent (defined as past 30-day use vs former use and never use). Objective sleep was assessed using data from 7-day wrist actigraphy, while subjective sleep was evaluated using the Pittsburgh Sleep Quality Index (PSQI).
Outcomes included objective sleep duration (categorized as short [<6 h], optimal [6–8 h], or long [>8 h]), sleep percentage (low percentage of time asleep was <85 percent), sleep fragmentation (defined as the index of restlessness during sleep), and wakefulness after sleep onset (WASO; prolonged WASO was defined as ≥30 min) and subjective sleep quality (poor sleep quality was defined as PSQI >5).
In multivariable analyses, each additional cannabis-year was associated with increased odds of low sleep percentage (odds ratio [OR], 1.10, 95 percent CI, 1.06–1.14), high sleep fragmentation (OR, 1.04, 95 percent CI, 1.01–1.08), and prolonged WASO (OR, 1.21, 95 percent CI, 1.10–1.34).
Compared with participants who formerly used cannabis and those who had never used, participants with recent cannabis use were more likely to have low sleep percentage, high fragmentation, prolonged WASO, and long (vs optimal) sleep duration (eg, vs never use: OR for prolonged WASO, 3.23; OR for long sleep duration, 4.60).
Cannabis use showed no association with subjective sleep quality.